Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, RAPID MICRO BIOSYSTEMS, INC. reported revenue of $34M, up 19.7% year over year. Operating margin was -141.1% and net margin -140.3%, on a free-cash-flow margin of -95.0% with capital expenditure at 2.5% of revenue. Every figure is computed directly from RPID's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $34M | -141.1% | -140.3% |
| FY2024 | $28M | -178.0% | -167.2% |
| FY2023 | $23M | -251.2% | -233.0% |
| FY2022 | $17M | -369.0% | -354.9% |
| FY2021 | $23M | -203.3% | -316.5% |
How does RPID compare against its actual peer set?
The full CompsDesk Peer Benchmark Pack: up to 14 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, provenance for every number, board-ready PDF + CSV. One-off $249.
Related in the same sector: A · AEHR · AERG · AEVA · AIRI · ALGN
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.